Dec 17 (Reuters) - Healius Ltd (HLS) :
- TO ACQUIRE 100% OF AGILEX BIOLABS PTY LTD FOR AN ENTERPRISE VALUE OF A$301.3 MILLION
- ACQUISITION IS EXPECTED TO DELIVER LOW SINGLE DIGIT EPS ACCRETION IN FIRST FULL YEAR OF OWNERSHIP
- ESTIMATED CY22 REVENUE AND EBITDA IS WITHIN A RANGE OF A$36-40 MILLION AND A$14-16 MILLION, RESPECTIVELY
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
79.5¢ |
Change
-0.020(2.45%) |
Mkt cap ! $577.2M | |||
| Open | High | Low | Value | Volume |
| 81.0¢ | 82.5¢ | 78.8¢ | $2.274M | 2.833M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 99331 | 79.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 79.5¢ | 37860 | 44 |
View Market Depth
| Last trade - 13.28pm 13/08/2025 (20 minute delay) ? |
| HLS (ASX) Chart |